Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 35% ± 18% | |
brain | 19 studies | 68% ± 20% | |
peripheral blood | 14 studies | 32% ± 15% | |
intestine | 10 studies | 24% ± 9% | |
eye | 10 studies | 53% ± 23% | |
kidney | 8 studies | 34% ± 19% | |
liver | 6 studies | 38% ± 21% | |
heart | 6 studies | 53% ± 20% | |
uterus | 5 studies | 31% ± 11% | |
lymph node | 5 studies | 25% ± 6% | |
breast | 5 studies | 35% ± 12% | |
bone marrow | 4 studies | 33% ± 21% | |
prostate | 4 studies | 41% ± 10% | |
adipose | 4 studies | 58% ± 26% | |
pancreas | 3 studies | 45% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4145.82 | 1444 / 1445 | 100% | 29.07 | 183 / 183 |
lung | 100% | 6600.86 | 578 / 578 | 99% | 18.88 | 1147 / 1155 |
brain | 99% | 4250.85 | 2612 / 2642 | 100% | 27.91 | 702 / 705 |
breast | 100% | 6472.79 | 459 / 459 | 98% | 24.86 | 1099 / 1118 |
prostate | 100% | 4077.13 | 245 / 245 | 98% | 21.50 | 490 / 502 |
stomach | 100% | 3816.40 | 359 / 359 | 98% | 19.74 | 279 / 286 |
thymus | 100% | 5841.19 | 653 / 653 | 97% | 19.76 | 585 / 605 |
intestine | 100% | 5016.96 | 966 / 966 | 97% | 17.38 | 509 / 527 |
pancreas | 98% | 2470.82 | 323 / 328 | 98% | 21.18 | 174 / 178 |
kidney | 100% | 3037.06 | 89 / 89 | 96% | 20.77 | 862 / 901 |
ovary | 100% | 6070.08 | 180 / 180 | 96% | 11.62 | 411 / 430 |
uterus | 100% | 6226.49 | 170 / 170 | 95% | 15.76 | 436 / 459 |
bladder | 100% | 3968.14 | 21 / 21 | 93% | 13.53 | 471 / 504 |
adrenal gland | 100% | 3598.17 | 258 / 258 | 92% | 13.18 | 212 / 230 |
skin | 100% | 4784.10 | 1807 / 1809 | 86% | 13.44 | 404 / 472 |
liver | 100% | 2380.97 | 226 / 226 | 81% | 9.38 | 329 / 406 |
adipose | 100% | 6306.40 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4892.25 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 5113.06 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.53 | 1 / 1 |
muscle | 100% | 2786.74 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 2711.55 | 834 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 12.29 | 42 / 45 |
peripheral blood | 91% | 4067.96 | 845 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 12.97 | 26 / 29 |
eye | 0% | 0 | 0 / 0 | 53% | 5.76 | 42 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007596 | Biological process | blood coagulation |
GO_0006338 | Biological process | chromatin remodeling |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000118 | Cellular component | histone deacetylase complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0046966 | Molecular function | nuclear thyroid hormone receptor binding |
GO_0031490 | Molecular function | chromatin DNA binding |
GO_0032454 | Molecular function | histone H3K9 demethylase activity |
GO_0051213 | Molecular function | dioxygenase activity |
GO_0005515 | Molecular function | protein binding |
GO_0003712 | Molecular function | transcription coregulator activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | JMJD1C |
Protein name | Probable JmjC domain-containing histone demethylation protein 2C (EC 1.14.11.-) (Jumonji domain-containing protein 1C) (Thyroid receptor-interacting protein 8) (TR-interacting protein 8) (TRIP-8) Lysine-specific demethylase (EC 1.14.11.65) Jumonji domain containing 1C JMJD1C protein |
Synonyms | KIAA1380 JHDM2C TRIP8 |
Description | FUNCTION: Probable histone demethylase that specifically demethylates 'Lys-9' of histone H3, thereby playing a central role in histone code. Demethylation of Lys residue generates formaldehyde and succinate. May be involved in hormone-dependent transcriptional activation, by participating in recruitment to androgen-receptor target genes (By similarity). . FUNCTION: Histone demethylase that specifically demethylates 'Lys-9' of histone H3, thereby playing a central role in histone code. . |
Accessions | H7BXU7 ENST00000399262.7 [Q15652-1] B7ZLC8 Q15652 A0PJE4 ENST00000542921.5 [Q15652-3] ENST00000327520.7 |